Hematological toxicities with Lutathera® for neuroendocrine neoplasms: post-marketing surveillance data from the US-FDA

Endocrine. 2024 Dec;86(3):1192-1193. doi: 10.1007/s12020-024-03915-z. Epub 2024 Jun 7.
No abstract available

Publication types

  • Letter